Ciphergen s CEO Talks about Bringing Mass Specs to the Masses

Nov 11, 2002

Premium

At A Glance

Name: William Rich

Age: 58

Position: President and CEO, Ciphergen Biosystems

Prior Experience: PhD, University of North Carolina at Chapel Hill

Postdoctoral research, Duke University

Co-founder of chromatography company Dionex

Spent four years at pharmaceutical company Sepracor as senior vice president and general manager

Were you one of the co-founders of Ciphergen?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

An Expensive Deal

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Figuring Out Who It'll Work For

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

This Week in Nature

In Nature this week: paternal age associated with de novo mutations in children, and more.

Ye Old P-Value

Nature News writes that researchers are still wrangling over the role of the p-value.

Featured White Papers

Lipid Removal With Reference Applications in Serum and Bile Proteomics

Albumin & IgG Removal Reference Applications

95-plex Immune Cell Phenotyping Assay

Oct

10

Featured Webinar

GenomeWeb/ABRF 2017 Webinar Series: Ask the Experts: Ensuring High-Quality Proteomic Studies with Core Lab Resources

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.

Main menu